BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 25306385)

  • 1. Liver-specific magnetic resonance contrast medium in the evaluation of chronic liver disease.
    Reis MA; Baroni RH
    Einstein (Sao Paulo); 2015; 13(2):326-9. PubMed ID: 26154554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.
    Hostalek U; Gwilt M; Hildemann S
    Drugs; 2015 Jul; 75(10):1071-94. PubMed ID: 26059289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The initial experience of the upper abdominal CT angiography using low-concentration contrast medium on dual energy spectral CT.
    Xin L; Yang X; Huang N; Du X; Zhang J; Wang Y; Hou L; Gao J
    Abdom Imaging; 2015 Oct; 40(7):2894-9. PubMed ID: 26036793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient labeling in vitro with non-ionic gadolinium magnetic resonance imaging contrast agent and fluorescent transfection agent in bone marrow stromal cells of neonatal rats.
    Li YQ; Tang Y; Fu R; Meng QH; Zhou X; Ling ZM; Cheng X; Tian SW; Wang GJ; Liu XG; Zhou LH
    Mol Med Rep; 2015 Jul; 12(1):913-20. PubMed ID: 25816076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of gadoxetic acid-enhanced MR imaging to characterize atypical cirrhotic nodules detected on dynamic CT images.
    Chou CT; Wu WP; Chen CB; Su WW; Chen RC; Chen YL
    PLoS One; 2014; 9(10):e107869. PubMed ID: 25310817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Imaging Diagnosis of Hepatocellular Carcinoma.
    Chartampilas E; Rafailidis V; Georgopoulou V; Kalarakis G; Hatzidakis A; Prassopoulos P
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
    Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging in cirrhosis and hepatocellular carcinoma.
    Barr DC; Hussain HK
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.
    Golfieri R; Garzillo G; Ascanio S; Renzulli M
    Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-assisted evaluation of contrast kinetics for detection of hepatocellular carcinoma on magnetic resonance imaging.
    Chaturvedi A; Bhargava P; Kolokythas O; Mitsumori LM; Maki JH
    Curr Probl Diagn Radiol; 2015; 44(1):8-14. PubMed ID: 25306385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images.
    Kwon HJ; Byun JH; Kim JY; Hong GS; Won HJ; Shin YM; Kim PN
    Abdom Imaging; 2015 Jan; 40(1):64-75. PubMed ID: 24997560
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.